Being the dry powder incoming device possessing the medicine composition inside, the aforementioned medicine composition (6 , 11 , 16 and 17 ) - 6,9 - jihuruoro - 17- {[(fluoro methyl) thio] carbonyl} - 11 - hydroxy - 16 - methyl - 3 - okisoandorosuta - 1,4 - diene - 17 - iru 2 - hurankarubokishireto or includes the incoming device and the hygroscopicity substance and the dry powder incoming device and the hygroscopicity substance which include the chemical compound which is those solvent dishes dressed with sauce, it includes with the package which decides the capacity which is closed, the capacity which is closed shows 20% - 40% relative humidity, the medicine product.< Selective figure >It is not内部に医薬組成物を有する乾燥粉末吸入装置であって、前記医薬組成物が(6α,11β,16α,17α)-6,9-ジフルオロ-17-{[(フルオロメチル)チオ]カルボニル}-11-ヒドロキシ-16-メチル-3-オキソアンドロスタ-1,4-ジエン-17-イル2-フランカルボキシレート又はその溶媒和物である化合物を含む吸入装置と、吸湿性物質と、乾燥粉末吸入装置及び吸湿性物質を包含し、閉じられた容積を確定するパッケージとを含み、閉じられた容積が20%~40%の相対湿度を示す、薬物製品。【選択図】なし
